You just read:

Taiwan National Health Insurance Administration of the Ministry of Health and Welfare Approves Epclusa(R) (sofosbuvir/velpatasvir) for Reimbursement

News provided by

Gilead Sciences, Inc.

30 May, 2019, 07:16 BST